NCT04837183View on ClinicalTrials.gov

Catheter Ablation of Ventricular Arrhythmia Reduces Skin Sympathetic Activity

TerminatedOBSERVATIONAL

Enrollment

30

Participants

Timeline

Start Date

November 15, 2021

Primary Completion Date

January 1, 2024

Study Completion Date

January 1, 2024

Conditions

Ventricular Tachycardia

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors

collaborator

Cedars-Sinai Medical Center

OTHER

lead

Mayo Clinic

OTHER

NCT04837183 - Catheter Ablation of Ventricular Arrhythmia Reduces Skin Sympathetic Activity | Biotech Hunter | Biotech Hunter